IIA R&D Fund

The R&D Fund is IIA's flagship programme — described by IIA as the largest financial incentive awarded by the State of Israel for Israeli corporations' R&D activity. It is open to all sectors (hardware, software, communications, complex systems, life sciences, medical devices, cyber, IoT, fintech, cleantech) and to companies at all stages, from startups (after the Early Stage Companies Incentive Program merged into the R&D Fund in 2020) to investment-intensive corporations. Funding ranges from 20% to 50% of approved R&D expenditure. Israeli Development Zones (peripheral regions) receive +10% additional support, and the Gaza Strip area receives +25%. Preferential rates apply to startups owned by minority populations, Ultra-Orthodox, or women entrepreneurs: up to 75% in the first year and 70% in the second year. Grants are royalty-back conditional: companies repay via royalty payments on sales only if commercialisation succeeds. Standard royalty rates are 3-5% of sales, capped at the cumulative grant amount plus LIBOR interest. If commercialisation fails, no repayment is required. The programme is open year-round; applications are reviewed continuously by IIA's research committee.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.